肝乐欣胶囊治疗急性肝炎的物质基础及作用机制  

Material basis and action mechanism of Ganlexin Capsules in the treatment of Acute Hepatitis

作　　者：姜运会 成果 付朝举 郭波波 田昌林 张楠楠 李军 JIANG Yunhui;CHENG Guo;FU Chaoju;GUO Bobo;TIAN Changlin;ZHANG Nannan;LI Jun(School of Basic Medicine,Guizhou University of Traditional Chinese Medicine,Guiyang 550025,China;School of Pharmacy,Guizhou University of Traditional Chinese Medicine,Guiyang 550025,China)

机构地区：[1]贵州中医药大学基础医学院,贵州贵阳550025 [2]贵州中医药大学药学院,贵州贵阳550025

出　　处：《贵州科学》2024年第3期46-51,96,共7页Guizhou Science

基　　金：贵州省卫生健康委科学技术基金,项目编号:gzwkj2023-266。

摘　　要：目的:基于网络药理学和分子对接技术深入探讨肝乐欣胶囊诊治急性肝炎的物质基础及作用机制。方法:充分利用ETCM、Uniprot、HERB、SwissTargetPrediction和TCMSP数据库遴选肝乐欣胶囊的化学成分及靶点;通过DisGeNET、GeneCards和OMIM在线数据库遴选收集急性肝炎的疾病靶点,与肝乐欣胶囊的靶点通过韦恩图获取交集,结合Cytoscape软件构建药物-成分-靶点图;STRING对交集靶点做PPI分析,PPI分析的最终结果由Cytoscape进行可视化;R语言进行GO和KEGG的通路富集分析;使用GSE27850和GSE111449进行基因差异表达和ROC验证;最后进行分子对接,明确肝乐欣胶囊发挥作用的主要化合物。结果:共得到IL6、PCOLCE、CA3、SERPINE1、EGFR、SELE等236个交集基因,GO和KEGG通路富集分析结果显示其主要参与调控PI3K-Akt、TNF等信号通路;分子对接显示EGFR的蛋白可与肝乐欣胶囊中的维他命E、木犀草素、芍药苷等多种成分进行结合。结论:肝乐欣胶囊主要通过木犀草素、芍药苷等靶向EGFR参与PI3K-Akt、TNF等信号通路而治疗急性肝炎。Based on Network Pharmacology and molecular docking technology,we investigated the material basis and action mechanism of Ganlexin Capsules in the treatment of Acute Hepatitis.The chemical components and targets of Ganlexin Capsules were selected in ETCM,Uniprot,HERB,SwissTargetPrediction and TCMSP databases.The disease targets of Acute Hepatitis were selected in DisGeNET,GeneCards and OMIM online databases and intersected with the targets of Ganlexin Capsules by Venn diagram.The drug-component-target map was constructed with Cytoscape software.PPI analysis of the intersecting targets was performed by STRING,and the final results of PPI analysis were visualized by Cytoscape.R language was used for GO and KEGG pathway enrichment analysis.GSE27850 and GSE111449 were used for differential gene expression and ROC validation.Finally,molecular docking was performed to clarify the main active compounds in Ganlexin Capsules.A total of 236 intersecting genes were obtained,including IL6,PCOLCE,CA3,SERPINE1,EGFR,SELE,etc.The results of GO and KEGG pathway enrichment analysis showed that they were mainly involved in the regulation of PI3K-Akt,TNF and other signaling pathways.Molecular docking showed that the EGFR protein could bind to a variety of components such as vitamin E,lignocaine and paeoniflorin in Ganlexin Capsules.In conclusion,Ganlexin capsule mainly treats Acute Hepatitis by targeting EGFR involved in PI3K-Akt and TNF signaling pathways through lignocaine and paeoniflorin.

关 键 词：急性肝炎 肝乐欣胶囊 网络药理学 

分 类 号：R285[医药卫生—中药学]